Login Register Cart 0
Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Mechanistic Study on the Possible Role of Embelin in Treating Neurodegenerative Disorders

Author(s): Anika, Rimpi Arora*, Sharma A. Virendra and Pooja A. Chawla*

Volume 23, Issue 1, 2024

Published on: 07 February, 2023

Page: [55 - 66] Pages: 12

DOI: 10.2174/1871527322666230119100053

Price: $65

Abstract

Embelin (EMB) (2,5-Dihydroxy-3-undecyl-1,4-benzoquinone) is a natural benzoquinone extracted mainly from Embelia ribes (ER) and appear as vivid orange dots beneath the fruit's pericarp. It is being used to treat various diseases since ancient times in India. It has been ascribed as one of the 32 ayurvedic drugs of national importance in the National Medicinal Plant Board set up by the Government of India under the Ministry of Indian System of Medicine and Homeopathy. Embelin prevents neuronal oxidative damage by decreasing the peroxidation of lipids. Along with having antioxidant properties, it also prevents the production of amyloid-protein-related fibrils and blocks the progression of inflammatory cascades. Due to embelin's ability to cross the blood-brain barrier, its neuroprotective effects have been studied in the past using in vitro models of neuronal disorders such as convulsion and epilepsy, Alzheimer's disease, anxiety and depression, traumatic brain injury, cerebral ischemia, Huntington's disease, and multiple sclerosis. In addition to its neuroprotective effects, its role as an antitubercular, anti-cancer, antioxidant, astringent, anti-inflammatory, anti-bacterial, contraceptive, carminative, diuretic, and anthelmintic agent has also been studied. With docking studies and recent advancements in formulations of embelin including polyethylene and embelin micelles and embelin noisome preparations, embelin can prove to be a promising compound for its therapeutic actions in a wide range of diseases and disorders. The findings of docking studies suggest the binding ability of embelin to be similar to the standard drug in their respective disorders. In this review and docking analysis, we bring an outline of scientific evidence concerning the neuroprotective actions of embelin, still, further research is required for its prospective as a chief compound in clinical approaches.

« Previous Next »
Graphical Abstract

[1]
Souravi K, Rajasekharan PE. Ethnopharmacological Uses of Embelia ribes Burm. F. - A Review. IOSR J Pharm Biol Sci 2014; 9(3): 23-30.
[http://dx.doi.org/10.9790/3008-09332330]
[2]
Durg S, Veerapur VP, Neelima S, Dhadde SB. Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis. Biomed Pharmacother 2017; 86: 195-204.
[http://dx.doi.org/10.1016/j.biopha.2016.12.001] [PMID: 27984799]
[3]
Poojari R. Embelin – a drug of antiquity: shifting the paradigm towards modern medicine. 2014; 23(3): 427-44.
[4]
Basha NJ, Basavarajaiah SM, Baskaran S, Kumar P. A comprehensive insight on the biological potential of embelin and its derivatives. In:Natural Product Research. Taylor & Francis 2021.
[5]
Nagamani V, Rani AS, Satyakala M, Ch GNV. Reddy rashekar. High performance liquid chromatography (HPLC) analysis of embelin in different samples of Embelis ribes Burm. f. - a threatened medicinal plant of India. J Med Plants Res 2013; 7(24): 1761-7.
[6]
Nuthakki VK, Sharma A, Kumar A, Bharate SB. Identification of embelin, a 3‐undecyl‐1,4‐benzoquinone from Embelia ribes as a multitargeted anti‐Alzheimer agent. Drug Dev Res 2019; 80(5): ddr.21544.
[http://dx.doi.org/10.1002/ddr.21544] [PMID: 31050027]
[7]
Harish GU, Danapur V, Jain R, Patell VM. Endangered Medicinal Plant Embelia ribes Burm.f.- A Review. Pharmacogn J 2012; 4(27): 6-19.
[http://dx.doi.org/10.5530/pj.2012.27.2]
[8]
Feresin GE, Tapia A, Sortino M, et al. Bioactive alkyl phenols and embelin from Oxalis erythrorhiza. J Ethnopharmacol 2003; 88(2-3): 241-7.
[http://dx.doi.org/10.1016/S0378-8741(03)00258-7] [PMID: 12963150]
[9]
Podolak I, Galanty A, Janeczko Z. Cytotoxic activity of embelin from Lysimachia punctata. Fitoterapia 2005; 76(3-4): 333-5.
[http://dx.doi.org/10.1016/j.fitote.2005.02.006] [PMID: 15890461]
[10]
Pandya V, Patel J, Technol DP-D. Formulation and optimization of nanosuspensions for enhancing simvastatin dissolution using central composite design. dissolutiontechcom 2011; 18(3): 40-5.
[11]
Singh B, Guru SK, Sharma R, et al. Synthesis and anti-proliferative activities of new derivatives of embelin. Bioorg Med Chem Lett 2014; 24(20): 4865-70.
[http://dx.doi.org/10.1016/j.bmcl.2014.08.052] [PMID: 25240254]
[12]
Fan Y, Zhao L, Huang X, et al. Pharmacokinetic and bioavailability studies of α-viniferin after intravenous and oral administration to rats. J Pharm Biomed Anal 2020; 188: 113376.
[http://dx.doi.org/10.1016/j.jpba.2020.113376] [PMID: 32502955]
[13]
Latha C. Microwave-assisted extraction of embelin from Embelia ribes. Biotechnol Lett 2007; 29(2): 319-22.
[http://dx.doi.org/10.1007/s10529-006-9243-z] [PMID: 17124632]
[14]
Lu H, Wang J, Wang Y, Qiao L, Zhou Y. Embelin and its role in chronic diseases. Adv Exp Med Biol 2016; 928: 397-418.
[http://dx.doi.org/10.1007/978-3-319-41334-1_16] [PMID: 27671825]
[15]
Parmar K, Patel J, Sheth N. Formulation and optimization of Embelin nanosuspensions using central composite design for dissolution enhancement. J Drug Deliv Sci Technol 2015; 29: 1-7.
[http://dx.doi.org/10.1016/j.jddst.2015.05.011]
[16]
Peng M, Huang B, Zhang Q, et al. Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells11These authors contributed equally to this work. Cancer Lett 2014; 354(2): 407-16.
[http://dx.doi.org/10.1016/j.canlet.2014.08.011] [PMID: 25128650]
[17]
Pathan RA, Bhandari U. Preparation & characterization of embelin–phospholipid complex as effective drug delivery tool. J Incl Phenom Macrocycl Chem 2011; 69(1-2): 139-47.
[http://dx.doi.org/10.1007/s10847-010-9824-2]
[18]
Bhuvanendran S, Bakar SNS, Kumari Y, Othman I, Shaikh MF, Hassan Z. Embelin Improves the Spatial Memory and Hippocampal Long-Term Potentiation in a Rat Model of Chronic Cerebral Hypoperfusion. Sci Rep 2019; 9(1): 14507.
[http://dx.doi.org/10.1038/s41598-019-50954-y] [PMID: 31601902]
[19]
Fu X, Pang X, Qi H, Chen S, Li Y, Tan W. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro. Clin Transl Oncol 2016; 18(3): 277-82.
[http://dx.doi.org/10.1007/s12094-015-1363-2] [PMID: 26209051]
[20]
Rhodus NL, Cheng B, Myers S, Miller L, Ho V, Ondrey F. The feasibility of monitoring NF-κB associated cytokines: TNF-α IL-1α IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog 2005; 44(2): 77-82.
[http://dx.doi.org/10.1002/mc.20113] [PMID: 16075467]
[21]
Podolak I. Strzałka M. Qualitative and quantitative lc profile of embelin and rapanone in selected lysimachia species. Chromatogr 2008; 67(5): 471-5.
[http://dx.doi.org/10.1365/s10337-007-0511-4]
[22]
Prasad SB. Embelin: A potential Benzoquinone. International Journal of Current Pharmaceutical Review and Research 2017; 8(3)
[http://dx.doi.org/10.25258/ijcprr.v8i03.9204]
[23]
Sreepriya M, Bali G. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 2005; 76(6): 549-55.
[http://dx.doi.org/10.1016/j.fitote.2005.04.014] [PMID: 16009505]
[24]
Li Z, Chen SJ, Yu XA, Li J, Gao XM, He J, et al. Pharmacokinetic and bioavailability studies of embelin after intravenous and oral administration to rats. Evidence-based Complement Altern Med 2019.
[http://dx.doi.org/10.1155/2019/9682495]
[25]
Kundap UP, Bhuvanendran S, Kumari Y, Othman I, Shaikh MF. Plant derived phytocompound, embelin in CNS disorders: A systematic review. Front Pharmacol 2017; 8: 76.
[http://dx.doi.org/10.3389/fphar.2017.00076] [PMID: 28289385]
[26]
Bhuvanendran S, Hanapi NA, Ahemad N, Othman I, Yusof SR, Shaikh MF. Embelin, a potent molecule for Alzheimer’s disease: Embelin, a potent molecule for Alzheimer’s disease A proof of concept from blood-brain barrier permeability, acetylcholinesterase inhibition and molecular docking studies Embelin. Front Neurosci 2019; 13: 495.
[http://dx.doi.org/10.3389/fnins.2019.00495] [PMID: 31156375]
[27]
Siegel C, Li J, Liu F, Benashski SE, McCullough LD. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia. Proc Natl Acad Sci USA 2011; 108(28): 11662-7.
[http://dx.doi.org/10.1073/pnas.1102635108] [PMID: 21709246]
[28]
Mahendran S, Thippeswamy BS, Veerapur VP, Badami S. Anticonvulsant activity of embelin isolated from Embelia ribes. Phytomedicine 2011; 18(2-3): 186-8.
[http://dx.doi.org/10.1016/j.phymed.2010.04.002] [PMID: 20605710]
[29]
K G. GABA and epilepsy: basic concepts from preclinical research. Epilepsia 1992; 33 (Suppl. 5): S3-S12.
[30]
Gajcy K. Lochyński S, Librowski T. A role of GABA analogues in the treatment of neurological diseases. Curr Med Chem 2010; 17(22): 2338-47.
[http://dx.doi.org/10.2174/092986710791698549] [PMID: 20491640]
[31]
Gupta G, Kazmi I, Afzal M, Upadhyay G, Singh R, Habtemariam S. Antidepressant-like activity of Embelin isolated from Embelia ribes. herbalanalysiscouk 2013; 2013(1): 87-95. Available from: herbalanalysis.co.uk
[32]
Afzal M, Gupta G, Kazmi I, et al. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes. Biomed Aging Pathol 2012; 2(2): 45-7.
[http://dx.doi.org/10.1016/j.biomag.2012.03.003]
[33]
Möhler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012; 62(1): 42-53.
[http://dx.doi.org/10.1016/j.neuropharm.2011.08.040] [PMID: 21889518]
[34]
Lobato KR, Cardoso CC, Binfaré RW, et al. α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behav Brain Res 2010; 209(2): 249-59.
[http://dx.doi.org/10.1016/j.bbr.2010.02.002] [PMID: 20144659]
[35]
Klumpers UMH, Veltman DJ, Drent ML, et al. Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging 2010; 37(3): 565-74.
[http://dx.doi.org/10.1007/s00259-009-1292-9] [PMID: 19890631]
[36]
Ghose S, Winter MK, McCarson KE, Tamminga CA, Enna SJ. The GABAB receptor as a target for antidepressant drug action. Br J Pharmacol 2011; 162(1): 1-17.
[http://dx.doi.org/10.1111/j.1476-5381.2010.01004.x] [PMID: 20735410]
[37]
Wang B, Chen X, Zhou T, Wang X. Antidepressant-like effects of embelin and its possible mechanisms of action in chronic unpredictable stress-induced mice. Neurol Res 2018; 40(8): 1-11.
[http://dx.doi.org/10.1080/01616412.2018.1460705] [PMID: 29681219]
[38]
Holthoff VA, Koeppe RA, Frey KA, et al. Positron emission tomography measures of benzodiazepine receptors in Huntington’s disease. Ann Neurol 1993; 34(1): 76-81.
[http://dx.doi.org/10.1002/ana.410340114] [PMID: 8390806]
[39]
Dhadde SB, Nagakannan P, Roopesh M, et al. Effect of embelin against 3-nitropropionic acid-induced Huntington’s disease in rats. Biomed Pharmacother 2016; 77: 52-8.
[http://dx.doi.org/10.1016/j.biopha.2015.11.009] [PMID: 26796265]
[40]
Lassmann H. Multiple Sclerosis Pathology 2018; 1-15.
[http://dx.doi.org/10.1101/cshperspect.a028936]
[41]
Yan J, Greer J. NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis. CNS Neurol Disord Drug Targets 2008; 7(6): 536-57.
[http://dx.doi.org/10.2174/187152708787122941] [PMID: 19128210]
[42]
Hu R, Wu B, Zhang GJ, et al. Effect of Embelin on proliferation, differentiation and aopotosis of HL-60 cells. Zhonghua Xue Ye Xue Za Zhi 2010; 31(7): 442-5.
[PMID: 21122396]
[43]
Xue Z, Ge Z, Zhang K, Sun R, Yang J, et al. Embelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-β/β-catenin and STAT3 signaling pathways. Springer 2013; 49(2): 1087-101.
[44]
Barbalho CA, Nunes-de-Souza RL, Canto-de-Souza A. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: Evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test. Brain Res 2009; 1267: 65-76.
[http://dx.doi.org/10.1016/j.brainres.2009.02.042] [PMID: 19268657]
[45]
Hoda U, Jain S, Samim M, Jain GK, Agarwal NB. Embelin ameliorates cognitive dysfunction and progression of kindling in pentylenetetrazol-induced kindling in mice by attenuating brain inflammation. Epilepsy Behav 2021; 116: 107788.
[http://dx.doi.org/10.1016/j.yebeh.2021.107788] [PMID: 33581600]
[46]
Durg S. B NK, Vandal R, et al. Antipsychotic activity of embelin isolated from Embelia ribes: A preliminary study. Biomed Pharmacother 2017; 90: 328-31.
[http://dx.doi.org/10.1016/j.biopha.2017.03.085] [PMID: 28376400]
[47]
Shaikh A, Dhadde SB, Durg S, et al. Effect of embelin against lipopolysaccharide-induced sickness behaviour in mice. Phytother Res 2016; 30(5): 815-22.
[http://dx.doi.org/10.1002/ptr.5585] [PMID: 26890475]
[48]
Patel R, Science PG-O. Effect of embelin in middle cerebral artery occlusioninduced focal cerebral ischemia in rats. ejmoamscom 2014; 3(2): 135-9.
[49]
Plesnila N, von Baumgarten L, Retiounskaia M, et al. Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-κB transcriptional activity. Cell Death Differ 2007; 14(8): 1529-41.
[http://dx.doi.org/10.1038/sj.cdd.4402159] [PMID: 17464322]
[50]
Thippeswamy BS, Nagakannan P, Shivasharan BD, Mahendran S, Veerapur VP, Badami S. Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats. Neurotox Res 2011; 20(4): 379-86.
[http://dx.doi.org/10.1007/s12640-011-9258-7] [PMID: 21751076]
[51]
Arora R, Deshmukh R. Embelin attenuates intracerebroventricular Streptozotocin-Induced behavioral, biochemical, and neurochemical abnormalities in rats. Mol Neurobiol 2017; 54(9): 6670-80.
[http://dx.doi.org/10.1007/s12035-016-0182-y] [PMID: 27744573]
[52]
Saini P, Lakshmayya L, Bisht VS. Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f. Ayu 2017; 38(1-2): 76-81. [An Int Q J Res Ayurveda
[PMID: 29861598]
[53]
Maes M, Berk M, Goehler L, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012; 10(1): 66.
[http://dx.doi.org/10.1186/1741-7015-10-66] [PMID: 22747645]
[54]
MacDermott RP, Sanderson IR, Reinecker HC. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis 1998; 4(1): 54-67.
[http://dx.doi.org/10.1097/00054725-199802000-00009] [PMID: 9552229]
[55]
Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004; 5(6): 575-81.
[http://dx.doi.org/10.1038/ni1078] [PMID: 15164017]
[56]
Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31(2): 455-61.
[PMID: 19499576]
[57]
Olsen AB, Hetz RA, Xue H, et al. Effects of traumatic brain injury on intestinal contractility. Neurogastroenterol Motil 2013; 25(7): 593-e463.
[http://dx.doi.org/10.1111/nmo.12121] [PMID: 23551971]
[58]
Stephenson D, Yin T, Smalstig EB, et al. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J Cereb Blood Flow Metab 2000; 20(3): 592-603.
[http://dx.doi.org/10.1097/00004647-200003000-00017] [PMID: 10724123]
[59]
Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. In: F1000Research. 2018; 7
[60]
Wang Y, Santa-Cruz K, DeCarli C, Johnson JA. NAD(P)H: Quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer’s disease. Neurobiol Aging 2000; 21(4): 525-31.
[http://dx.doi.org/10.1016/S0197-4580(00)00114-7] [PMID: 10924765]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy